Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Genome editing Market, by region, 2019-2027 (USD Billion)
1.2.2. Genome editing Market, by Application, 2019-2027 (USD Billion)
1.2.3. Genome editing Market, by End use, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Genome editing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Genome editing Market Dynamics
3.1. Genome editing Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Success in pre-clinical models drives demands for genome editing therapeutics
3.1.1.2. Rising adoption in biotechnology
3.1.2. Market Challenges
3.1.2.1. Challenges with respect to clinical translation
3.1.3. Market Opportunities
3.1.3.1. Technological advancements in gene editing technologies
Chapter 4. Global Genome editing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Genome editing Market, by Application
5.1. Market Snapshot
5.2. Global Genome editing Market by Application, Performance - Potential Analysis
5.3. Global Genome editing Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
5.4. Genome editing Market, Sub Segment Analysis
5.4.1. Genetic Engineering
5.4.2. Clinical Applications
Chapter 6. Global Genome editing Market, by End use
6.1. Market Snapshot
6.2. Global Genome editing Market by End use, Performance - Potential Analysis
6.3. Global Genome editing Market Estimates & Forecasts by End use 2018-2027 (USD Billion)
6.4. Genome editing Market, Sub Segment Analysis
6.4.1. Biotechnology & Pharmaceutical Companies
6.4.2. Academic & Government Research Institutes
6.4.3. Contract Research Organizations (CROs)
Chapter 7. Global Genome editing Market, Regional Analysis
7.1. Genome editing Market, Regional Market Snapshot
7.2. North America Genome editing Market
7.2.1. U.S. Genome editing Market
7.2.1.1. Application breakdown estimates & forecasts, 2018-2027
7.2.1.2. End use breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Genome editing Market
7.3. Europe Genome editing Market Snapshot
7.3.1. U.K. Genome editing Market
7.3.2. Germany Genome editing Market
7.3.3. France Genome editing Market
7.3.4. Spain Genome editing Market
7.3.5. Italy Genome editing Market
7.3.6. Rest of Europe Genome editing Market
7.4. Asia-Pacific Genome editing Market Snapshot
7.4.1. China Genome editing Market
7.4.2. India Genome editing Market
7.4.3. Japan Genome editing Market
7.4.4. Australia Genome editing Market
7.4.5. South Korea Genome editing Market
7.4.6. Rest of Asia Pacific Genome editing Market
7.5. Latin America Genome editing Market Snapshot
7.5.1. Brazil Genome editing Market
7.5.2. Mexico Genome editing Market
7.6. Rest of The World Genome editing Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Precision Biosciences
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Merck KGaA
8.2.3. Cibus
8.2.4. Recombinetics, Inc
8.2.5. Sangamo
8.2.6. Editas Medicine
8.2.7. Crispr therapeutics
8.2.8. Intellia Therapeutics, Inc.
8.2.9. Caribou Biosciences, Inc
8.2.10. Cellectis
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption